Should all patients with chronic kidney disease receive an EPO-type drug?

Jeffrey S. Berns, MD
Associate Professor, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia

Address: Jeffrey S. Berns, MD, Penn Presbyterian Medical Center, Medical Office Building #240, 41 North 39th Street, Philadelphia, PA 19104; e-mail bernsj@uphs.upenn.edu

Jeffrey S. Berns, MD
Associate Professor, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia

Address: Jeffrey S. Berns, MD, Penn Presbyterian Medical Center, Medical Office Building #240, 41 North 39th Street, Philadelphia, PA 19104; e-mail bernsj@uphs.upenn.edu

Jeffrey S. Berns, MD
Associate Professor, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia

Address: Jeffrey S. Berns, MD, Penn Presbyterian Medical Center, Medical Office Building #240, 41 North 39th Street, Philadelphia, PA 19104; e-mail bernsj@uphs.upenn.edu